CNBX Pharmaceuticals Inc. (CNBX) stock
CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $197.79KP/E –Yield –
CNBX Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
CNBX Pharmaceuticals's operating margin for the twelve months ending Nov 30, 2024 was -1102.6%. For fiscal 2024 it was -448.3%, against -227.1% the year before. The highest annual figure on record is -227.1% in fiscal 2023.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Aug 31, 2024 | -448.3% | −221.2 |
| FY2023 | Aug 31, 2023 | -227.1% | +9633.3 |
| FY2022 | Aug 31, 2022 | -9860.4% | +32663.7 |
| FY2020 | Aug 31, 2020 | -42524.1% | −8961.1 |
| FY2019 | Aug 31, 2019 | -33563.0% | +6107.1 |
| FY2018 | Aug 31, 2018 | -39670.1% | −7054.0 |
| FY2017 | Aug 31, 2017 | -32616.1% | −32366.6 |
| FY2016 | Aug 31, 2016 | -249.5% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2024CQ1 2024 | Feb 29, 2024 | -508.0% | +1088.8 |
| Q1 FY2024CQ4 2023 | Nov 30, 2023 | -192.2% | +30198.1 |
| Q4 FY2023CQ3 2023 | Aug 31, 2023 | -161.5% | +36451.1 |
| Q3 FY2023CQ2 2023 | May 31, 2023 | -55.8% | +66079.2 |
| Q4 FY2022CQ3 2022 | Aug 31, 2022 | -1596.7% | +44917.3 |
| Q4 FY2020CQ3 2020 | Aug 31, 2020 | -30390.3% | +17216.5 |
| Q3 FY2020CQ2 2020 | May 31, 2020 | -36612.6% | −523.6 |
| Q2 FY2020CQ1 2020 | Feb 29, 2020 | -66135.0% | −27512.2 |
| Q1 FY2020CQ4 2019 | Nov 30, 2019 | -46514.0% | −26898.6 |
| Q4 FY2019CQ3 2019 | Aug 31, 2019 | -47606.8% | −23297.8 |
| Q3 FY2019CQ2 2019 | May 31, 2019 | -36089.0% | −7274.5 |
| Q2 FY2019CQ1 2019 | Feb 28, 2019 | -38622.7% | +49489.5 |
| Q1 FY2019CQ4 2018 | Nov 30, 2018 | -19615.4% | +10927.9 |
| Q4 FY2018CQ3 2018 | Aug 31, 2018 | -24309.0% | +13516.9 |
| Q3 FY2018CQ2 2018 | May 31, 2018 | -28814.5% | +1285.8 |
| Q2 FY2018CQ1 2018 | Feb 28, 2018 | -88112.2% | −72621.8 |
| Q1 FY2018CQ4 2017 | Nov 30, 2017 | -30543.3% | −30410.1 |
| Q4 FY2017CQ3 2017 | Aug 31, 2017 | -37825.9% | – |
| Q3 FY2017CQ2 2017 | May 31, 2017 | -30100.3% | – |
| Q2 FY2017CQ1 2017 | Feb 28, 2017 | -15490.3% | – |
| Q4 FY2016CQ3 2016 | Aug 31, 2016 | -133.2% | – |
See a number that looks wrong?